Clofazimine Latest Price and Buying Guide in 2024
Clofazimine (Clofazimine), as a drug specially designed to treat leprosy, was developed by the Swiss company Novartis (Novartis). The drug was first synthesized in 1957 and began to be used in clinical treatments in the 1960s. Its unique red dye compound form makes it stand out among many drugs.
Currently, clofazimine has been launched in China and has been successfully included in medical insurance, providing patients with convenience in purchasing medicine. Its price is affordable and can be purchased for only a few hundred yuan. For specific prices and medical insurance reimbursement details, patients are advised to consult their local hospital or pharmacy for accurate information. In comparison, the prices of generic drugs produced in India are even lower, with 100mg*100 capsules costing only five to six hundred yuan, making them the first choice for many patients.

The main effect of clofazimine is to inhibit the growth of Mycobacterium leprae (Mycobacterium leprae). By tightly binding to bacterial DNA, it effectively interferes with bacterial replication and transcription processes, thereby curbing bacterial growth and reproduction. In addition, the drug also exhibits significant anti-inflammatory effects and helps relieve inflammatory symptoms in patients with leprosy reactive stages.
Clofazimine has shown excellent results in the treatment of leprosy, especially for patients with multibacillary leprosy (MB leprosy). It is often used in combination with other anti-leprosy drugs, such as rifampicin and dapsone, to enhance the effectiveness of treatment and prevent the development of drug resistance. Not only that, clofazimine has also shown some efficacy in treating infections caused by other mycobacteria, such as non-tuberculous mycobacterial disease (NTM), as well as certain stubborn skin diseases (such as chronic eczema).
When using clofazimine for treatment, patients should strictly follow the doctor's instructions and never adjust the dosage or stop taking the medicine without authorization. Also, because clofazimine may increase skin sensitivity to sunlight, leading to sunburn, patients should avoid prolonged exposure to bright light. Pregnant and lactating women should be extremely cautious when using clofazimine, and treatment must be carried out under the advice and guidance of a doctor.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)